BNR (Burning Rock Biotech Limited American Depositary Shares) Stock Analysis - SEC Filings

Burning Rock Biotech Limited American Depositary Shares (BNR) is a publicly traded Healthcare sector company. As of May 21, 2026, BNR trades at $17.25 with a market cap of $176.12M and a P/E ratio of 0.00. BNR moved +0.00% today. Year to date, BNR is -31.78%; over the trailing twelve months it is +473.88%. Its 52-week range spans $2.18 to $41.72. Rallies surfaces BNR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find BNR SEC filings?

Rallies organizes BNR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

BNR Key Metrics

Key financial metrics for BNR
MetricValue
Price$17.25
Market Cap$176.12M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$41.72
52-Week Low$2.18
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest BNR News

Recent BNR Insider Trades

  • Han Yusheng bought 314.87K (~$5.47M) on Mar 31, 2026.

BNR Analyst Consensus

BNR analyst coverage data. Average price target: $0.00.

Common questions about BNR

Where can I find BNR SEC filings?
Rallies organizes BNR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show BNR 10-K and 10-Q filings?
Rallies organizes BNR SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is BNR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BNR. It does not provide personalized investment advice.
BNR

BNR